Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review

K. Hnin, C. Nguyen, K. Carson, B. Smith (Adelaide, Australia)

Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Session: Antibiotics, antifungals and other therapeutic options
Session type: Poster Discussion
Number: 4682
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Hnin, C. Nguyen, K. Carson, B. Smith (Adelaide, Australia). Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review. Eur Respir J 2014; 44: Suppl. 58, 4682

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014

Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Exacerbations in non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014

Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016

Effect of long term azithromycin on exacerbations in non CF bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health
Year: 2015

Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Respiratory infections in paediatrics: from pneumonia to cystic fibrosis
Source: Annual Congress 2007 - Infections year in review
Year: 2007


Mucus clearance devices in bronchiectasis: Indian experience
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013

The weight of radiological severity in patients with non-CF bronchiectasis
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Management of bronchiectasis in adults
Source: Eur Respir J 2015; 45: 1446-1462
Year: 2015



Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015


Effects of self-administered chest physiotherapy (SA-CP) in patients with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013